Effect of Praval bhasma (Coral calx), a natural source of rich calcium on bone mineralization in rats

Pharmacological Research

Volumn 48, Issue 6, 2003, Pages 593-599

  Reddy, Prabhakara N ^a   Lakshmana, M ^b   Udupa, U Venkatesh ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Government College of Pharmacy   (India)

^c Himalaya Health Care   (India)

Author keywords

Calcium deficiency; Osteoporosis; Ovariectomy; Praval bhasma

Indexed keywords

AYURVEDIC DRUG; CALCIUM; ESTROGEN; PHOSPHORUS; PRAVAL BHASMA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASH; BONE DENSITY; BONE MARROW; BONE MINERALIZATION; CALCIUM DEFICIENCY; CALCIUM URINE LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORAL; CORTICAL BONE; EPIPHYSIS; ESTROGEN DEFICIENCY; FEMALE; FEMUR; HISTOLOGY; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; PERIOSTEUM; PRAVAL BHASMA; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; TRABECULAR BONE; URINARY EXCRETION;

ANIMALS; BIOMECHANICS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; CALCIUM; FEMALE; FEMUR; MAGNESIUM; MEDICINE, AYURVEDIC; MICROSCOPY, ELECTRON, SCANNING; OSTREIDAE; OVARIECTOMY; PHOSPHORUS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 1542712444     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00224-X     Document Type: Article

References (22)

1. Bonjour J.P., Amman P., Rizzoli R. Importance of preclinical studies in the development of drugs for treatment of Osteoporosis: a review related to the 1998 WHO guidelines. Osteop. Internat. 9:1999;379-393.
2. Cummings S.R., Rubin S.M., Black D. The future of hip fractures in the United States: number, costs and potential effects of postmenopausal estrogen. Clin. Orthoped. 252:1990;163-166.
3. Lobo R.A. Benefits and risks of estrogen replacement therapy. Am. J. Obst. Gynecol. 173:1995;982-990.
4. Taylor M. Alternatives to the conventional hormone replacement therapy. Comp. Ther. 23:1997;514-532.
5. Dallal G.E., Dawson-Hughes B., Krall E.A., Sadowski L., Sahyoun N., Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N. Eng. J. Med. 323(13):1990;878-883.
6. Sowers MF. Epidemiology of calcium and Vitamin D in bone loss. In: Jo LF, Potischman N, editors. Proceeding of 76th Annual Meeting of the Federation of American Societies for Experimental Biology on Nutritional Epidemiology of Chronic Disease. CA: Anaheim; 1992. p. 413-7.
7. Mitra S.K., Rangesh P.R., Venkataranganna M.V., Udupa U.V., Gopumadhavan S., Sheshadri S.J.et al. The beneficial effect of OST-6 (Osteocare), a herbomineral preparation, in experimental osteoporosis. Phytomedicine. 8(3):2001;195-201.
8. Mitra S.K., Rangesh P.R., Venkataranganna M.V., Udupa U.V., Gopumadhavan S., Sheshadri S.J. Bone mineralization by OST-6 (Osteocare), a herbomineral preparation, in experimentally induced rickets in rats. Phytomedicine. 7(4):2000;265-272.
9. Donahue H.J., Mazzeo R.S., Horvath S.M. Endurance training and bone loss in calcium-deficient and ovariectomized rats. Metabology. 37(8):1988;741-744.
10. Kalu D.N., Liu C.C., Hardin R.R., Hollis B.W. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology. 124:1989;7-16.
11. Wegener OH. Density measurement. In: Schering AG, editor. Whole body computerized tomography. West Germany: Medico Scientific Book Series; 1983. p. 51-5.
12. Armstrong E., Aitken J.M., Anderson J.B. Osteoporosis after Oophorectomy in the mature female rat and the effect of oestrogen and/or progestogen replacement therapy in its prevention. J. Endocrinol. 55:1972;79-87.
13. Rude R.R., Kirchen M.E., Gruber H.E., Meyer M.H., Luck J.S., Crawford D.L. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption. Mag. Res. 12(4):1999;257-267.
14. Miller S.C., Bowman B.M. Comparison of bone loss during normal lactation with estrogen deficiency osteopenia and immobilization osteopenia in the rat. The Anat. Rec. 251:1998;265-274.
15. Bancroft JD, Cook HC. Manual of histological techniques. New York: Churchill Livingstone; 1980.
16. Civitelli R., Abbasi-Jarahomi R., Halstead L.R., Dimargonas A. Ipriflavone improves bone density and biomechanical properties of adult male rat bones. Calcif. Tissue Internat. 56(3):1999;215-219.
17. Dawson-Hughes B. Calcium supplementation and bone loss: a review of controlled clinical trials. Am. J. Clin. Nutr. 54:1990;274-280.
18. Asundi R.K., Dixit R.M. Spectrographic and X-ray fluorescence analysis of a class of ayurvedic medicines - calcium bhasmas. J. Res. Ind. Med. Yoga Homeopat. 13(1):1978;90-95.
19. Mazess R.B. Fracture risk: a role for compact bone. Calcif. Tissue Internat. 47:1990;191-193.
20. Higdon K., Scott A., Tucci M., Benghuzzi H., Tsao A., Puckett A.et al. The use of estrogen, DHEA and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model. Biomed. Sci. Instrum. 37:2001;281-286.
21. Ammann P, Rizzoli R, Bonjour JP. Preclinical evaluation of new therapeutic agents for osteoporosis. In: Meunier PJ, editor. Osteoporosis: diagnosis and management. London: Marktin Dinitz; 1988.
22. Miller S.C., Bowman M.B., Jee W.S.S. Available animals models of osteopenia-small and large. Bone. 17:1995;117-123.